Evidence for central opioid receptors in the immunomodulatory effects of morphine: Review of potential mechanism(s) of action

Journal of Neuroimmunology

Volumn 83, Issue 1-2, 1998, Pages 19-28

  Mellon, R Daniel ^a   Bayer, Barbara M ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Autonomic nervous system; Central nervous system; HPA axis; Morphine; Neuroimmunomodulation; Opioid receptors

Indexed keywords

17 METHYLMORPHINE; 17 METHYLNALTREXONE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; CONCANAVALIN A; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; METENKEPHALIN; MITOGENIC AGENT; MORPHINE; MORPHINE DERIVATIVE; MORPHINE SULFATE; MU OPIATE RECEPTOR; N (TETRAHYDROFURFURYL)NORMETAZOCINE; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NALTREXONE DERIVATIVE; OPIATE; OPIATE ANTAGONIST; OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DELAYED HYPERSENSITIVITY; DRUG MECHANISM; HUMORAL IMMUNITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOMODULATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

ANALGESICS, OPIOID; ANIMALS; HUMANS; MORPHINE; NEUROIMMUNOMODULATION; RECEPTORS, OPIOID;

EID: 0032520695     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00217-8     Document Type: Article

References (88)

1. Appel N.M., Kiritsy-Roy J.A., van Loon G.R. Mu receptors at discrete hypothalamic and brainstem sites mediate opioid peptide-induced increases in central sympathetic outflow. Brain Res. 378:1986;8-20.
2. Band L.C., Pert A., Williams W., De Costa B.R., Rice K.C., Weber R.J. Central μ-opioid receptors mediate suppression of natural killer activity in vivo. Prog. Neuro. Endocrinol. Immunol. 5:1992;95-101.
3. Bayer B.M., Daussin S., Hernandez M., Irvin L. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology. 29:1990;369-374.
4. Bayer, B.M., Hernandez, M., Irvin, L., 1990b. Suppression of lymphocyte activity after acute morphine administration appears to be glucocorticoid independent. In: Pawloski, A., Seminara, D., Watson, R. (Eds.), Alcohol, Immunomodulation, and AIDS. Alan R. Liss, New York, pp. 273-282.
5. Bayer B.M., Gastonguay M.R., Hernandez M.C. Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility. Immunopharmacology. 23:1992;117-124.
6. Bayer B.M., Brehio R.M., Ding X.Z., Hernandez M.C. Enhanced susceptibility of the immune system to stress in morphine-tolerant rats. Brain Behav. Immun. 8:1994;173-184.
7. Bayer B.M., Hernandez M.C., Ding X.Z. Tolerance and crosstolerance to the suppressive effects of cocaine and morphine on lymphocyte proliferation. Pharmacol. Biochem. Behav. 53:1996;227-234.
8. Bellinger D.L., Lorton D., Hamill R.W., Felten S.Y., Felten D.L. Acetylcholinesterase staining and choline acetyltransferase activity in the young adult rat spleen: lack of evidence for cholinergic innervation. Brain Behav. Immun. 7:1993;191-204.
9. Biagini R.E., Henningsen G.M., Klincewicz S.L. Immunological analysis of peripheral leukocytes from workers at an ethical narcotics manufacturing facility. Arch. Environ. Health. 50:1995;7-12.
10. Brown S.M., Stimmel B., Taub R.N., Kochwa S., Rosenfield R.E. Immunological dysfunction in heroin addicts. Arch. Intern. Med. 134:1974;1001-1006.
11. Bryant H., Bernton E., Holaday J. Morphine-induced immunosuppression: involvement of glucocorticoids and prolactin. NIDA Res. Mono. 90:1988;323.
12. Bryant H.U., Bernton E.W., Holaday J.W. Immunosuppressive effects of chronic morphine treatment in mice. Life Sci. 41:1987;1731-1738.
13. Bryant H.U., Bernton E.W., Kenner J.R., Holaday J.W. Role of the adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment. Endocrinology. 128:1991;3253-3258.
14. Bryant H.U., Roudebush R.E. Suppressive effects of morphine pellet implants on in vivo parameters of immune function. J. Pharmacol. Exp. Ther. 255:1990;410-414.
15. Carr D.J.J., Gebhardt B.M., Paul D. Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. J. Pharmacol. Exp. Ther. 264:1993;1179-1186.
16. Carr D.J.J., Mayo S., Gebhardt B.M., Porter J. Central α-adrenergic involvement in morphine-mediated suppression of splenic natural killer activity. J. Neuroimmunol. 53:1994;53-63.
17. Chao C.C., Sharp B.M., Pomeroy C., Filice G.A., Peterson P.K. Lethality of morphine in mice infected with Toxoplasma gondii. J. Pharmacol. Exp. Ther. 252:1990;605-609.
18. Chao C.C., Gekker G., Hu S., Sheng W.S., Portoghese P.S., Peterson P.K. Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin. Biochem. Pharmacol. 50:1995;715-722.
19. Chuang L.F., Killam K.F. Jr., Chuang R.Y. Increased replication of simian immunodeficiency virus in CEM×174 cells by morphine sulfate. Biochem. Biophys. Res. Commun. 195:1993;1165-1173.
20. Corbett, A.D., Paterson, S.J., Kosterlitz, H.W., 1993. Selectivity of ligands for opioid receptors. In: Akil, H., Simon, E.J. (Eds.), Handbook of Exp. Pharmacol.: Opioids I. Springer, New York, pp. 645-79.
21. Crone L.L., Conly J.M., Clark K.M., Chrichlow A.C., Wardell G.C., Zbitnew A., Rea L.M., Cronk S.L., Anderson C.M., Tan L.K., Albritton W.L. Recurrent herpes simplex virus labialis and the use of epidural morphine in obstetric patients. Anesth. Analg. 67:1988;318-323.
22. Curran J.W., Jaffe H.W., Hardy A.M., Morgan W.M., Selik R.M., Dondero T.J. Epidemiology of HIV infection and AIDS in the United States. Science. 239:1988;610-616.
23. Dhabhar F.S., Miller A.H., Stein M., McEwen B.S., Spencer R.L. Diurnal and acute stress-induced changes in distribution of peripheral blood leukocyte subpopulations. Brain Behav. Immun. 8:1994;66-79.
24. Dhabhar F.S., Miller A.H., McEwen B.S., Spencer R.L. Effects of stress on immune cell distribution: dynamics and hormonal mechanisms. J. Immunol. 154:1995;5511-5527.
25. Eisenberg R.M. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists. J. Pharmacol. Exp. Ther. 233:1985;863-869.
26. Fecho et al., 1993.
27. Fecho K., Maslonek K.A., Dykstra L.A., Lysle D.T. Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 277:1996;633-645.
28. Fecho K., Maslonek K.A., Dykstra L.A., Lysle D.T. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 276:1996;626-636.
29. Felten D.L., Felten S.Y., Carlson S.L., Olschowka J.A., Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol. 135:1985;755s-765s.
30. Flores C.M., Hernandez M.C., Hargreaves K.M., Bayer B.M. Restraint stress-induced elevations in plasma corticosterone and β-endorphin are not accompanied by alterations in immune function. J. Neuroimmunol. 28:1990;219-225.
31. Flores L.R., Hernandez M.C., Bayer B.M. Acute immunosuppressive effects of morphine: Lack of involvement of pituitary and adrenal factors. J. Pharmacol. Exp. Ther. 268:1994;1129-1134.
32. Flores L.R., Wahl S.M., Bayer B.M. Mechanisms of morphine-induced immunosuppression: Effects of acute morphine administration on lymphocyte trafficking. J. Pharmacol. Exp. Ther. 272:1995;1246-1251.
33. Flores L.R., Dretchen K.L., Bayer B.M. Potential role of the autonomic nervous system in the immunosuppressive effects of acute morphine administration. Eur. J. Pharmacol. 318:1996;437-446.
34. Freier D.O., Fuchs B.A. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity. J. Pharmacol. Exp. Ther. 270:1994;1127-1133.
35. Ginzberg H.M. Intravenous drug users and the acquired immune deficiency syndrome. Public Health Rev. 99:1984;206-212.
36. Gomes C., Svensson T.H., Trolin G. Effects of morphine on central catecholamine turnover, blood pressure and heart rate in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 294:1976;141-147.
37. Gordon, F.J., 1994. Opioids and the nucleus of the tractus solitarius: Effects on cardiovascular and baroreflex function. In: Barraco, I.R.A. (Ed.), Nucleus of the Solitary Tract. CRC Press, Boca Raton, FL, pp. 283-287.
38. Hamra J.G., Yaksh T.L. Equianalgesic doses of subcutaneous but not intrathecal morphine alter phenotypic expression of cell surface markers and mitogen-induced proliferation in rat lymphocytes. Anesthesiology. 85:1996;355-365.
39. Haracz J.L., Bloom A.S., Wang R.I.H., Tseng L. Effect of intraventricular β-endorphin and morphine on hypothalamic-pituitary-adrenal activity and the release of pituitary β-endorphin. Neuroendocrinology. 33:1981;170-175.
40. Haverkos H.W., Lange W.R. Serious infections other than human immunodeficiency virus among intravenous drug abusers. J. Infect. Dis. 161:1990;894-912.
41. Hernandez M.C., Flores L.R., Bayer B.M. Immunosuppression by morphine is mediated by central pathways. J. Pharmacol. Exp. Ther. 267:1993;1336-1341.
42. Hoffman, K.E., Maslonek, K.A., Dykstra, L.A., Lysle, D.T., 1995. Effects of central administration of morphine on immune status in Lewis and Wistar rats. In: Sharp, B.M., Eisenstein, T.K., Madden, J.J., Friedman, H. (Eds.), The Brain Immune Axis and Substance Abuse. Plenum Press, New York, pp. 155-159.
43. Hsueh C., Hiramoto R.N., Ghanta V.K. The central effect of methionine-enkephalin on NK cell activity. Brain Res. 578:1992;142-148.
44. Hsueh C., Chen S., Ghanta V.K., Hiramoto R.N. Expression of the conditioned NK cell activity is β-endorphin dependent. Brain Res. 678:1995;76-82.
45. Hussey H.H., Katz S. Infections resulting from narcotic addiction. Am. J. Med. 9:1950;186-193.
46. Iyengar S., Kim H.S., Wood P.L. μ-, δ-, κ- and ε-opioid modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides. Brain Res. 435:1987;220-226.
47. Janković B.D., Velijić J., Pešić G., Marić D. Enkephalinase-inhibitors modulate immune responses. Int. J. Neurosci. 59:1991;45-51.
48. Janković B.D., Radulović J. Enkephalins, brain and immunity: Modulation of immune responses by methionine-enkephalin injected into the cerebral cavity. Int. J. Neurosci. 67:1992;241-270.
49. Keller S.E., Weiss J.M., Schleifer S.J., Miller N.E., Stein M. Suppression of immunity by stress: effect of a graded series of stressors on lymphocyte stimulation in the rat. Science. 213:1981;1397-1400.
50. Keller S.E., Weiss J.M., Miller N.E., Stein M. Stress-induced suppression of immunity in adrenalectomized rats. Science. 221:1983;1301-1304.
51. Keller S.E., Schleifer S.J., Liotta A.S., Bond R.N., Farhoody N., Stein M. Stress-induced alterations of immunity in hypophysectomized rats. Proc. Natl. Acad. Sci. U.S.A. 85:1988;9297-9301.
52. Kiritsy-Roy J.A., Appel N.M., Bobbitt F.G., van Loon G.R. Effects of mu-opioid receptor stimulation in the hypothalamic paraventricular nucleus on basal and stress-induced catecholamine secretion and cardiovascular responses. J. Pharmacol. Exp. Ther. 239:1986;814-822.
53. Layon J., Idris A., Warzynski M., Sherer R., Brauner D., Patch O., McCulley D., Orris P. Altered T-lymphocyte subsets in hospitalized intravenous drug abusers. Arch. Intern. Med. 144:1984;1376-1380.
54. Lim A.T.W., Funder J.W. Stress-induced changes in plasma, pituitary and hypothalamic immunoreactive β-endorphin: effects of diurnal variation, adrenalectomy, corticosteroids, and opiate agonists and antagonists. Neuroendocrinology. 36:1983;225-234.
55. Lotti V.J., Kokka N., George R. Pituitary-adrenal activation following intrahypothalamic microinjection of morphine. Neuroendocrinology. 4:1969;326-332.
56. Lysle D.T., Hoffman K.E., Dykstra L.A. Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status. J. Pharmacol. Exp. Ther. 277:1996;1533-1540.
57. Madden J. IV, Akil H., Patrick R.L., Barchas J.D. Stress-induced parallel changes in central opioid levels and pain responsiveness in the rat. Nature. 265:1977;358-360.
58. Madden K.S., Sanders V.M., Felten D.L. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu. Rev. Pharmacol. Toxicol. 35:1995;417-448.
59. Marson L., Kiritsy-Roy J.A., van Loon G.R. μ-opioid peptide modulation of cardiovascular and sympathoadrenal responses to stress. Am. J. Physiol. 257:1996;R901-R908.
60. Mellon R.D., Hernandez M.C., Flores L.R., Kellar K.J., Bayer B.M. Immunosuppression by morphine, nicotine, and epibatidine: Autonomic nervous system involvement. FASEB J. 10:1996;A129.
61. Mellon R.D., Bayer B.M. Decreased blood lymphocyte proliferative responses mediated by central μ-receptors. Soc. Neurosci. Abstr. 22(2):1996;1314.
62. Mellon, R.D., Bayer, B.M., 1997. Central μ-opioid receptor suppression of peripheral lymphocyte activity. (Submitted).
63. Millan M.J., Przewlocki R., Jerlicz M., Gramsch C., Hollt V., Herz A. Stress-induced release of brain and pituitary β-endorphin: Major role of endorphins in generation of hyperthermia, not analgesia. Brain Res. 208:1981;325-338.
64. Nair M.P.N., Laing T.J., Schwartz S.A. Decreased natural and antibody-dependent cellular cytotoxic activities in intravenous drug abusers. Clin. Immunol. Immunopathol. 38:1986;68-78.
65. Nair M.P.N., Schwartz S.A., Polasani R., Hou J., Sweet A., Chadha K.C. Immunoregulatory effects of morphine on human leukocytes. Clin. Diagn. Lab. Immunol. 4:1997;127-132.
66. Pacifici R., Patrini G., Venier I., Parolaro D., Zuccaro P., Gori E. Effect of morphine and methadone acute treatment on immunological activity in mice: pharmacokinetic and pharmacodynamic correlates. J. Pharmacol. Exp. Ther. 269:1994;1112-1116.
67. Palm S., Mignat C., Kuhn K., Umbreit H., Barth J., Stüber F., Maier C. Phytohemaglutinin-dependent T-cell proliferation is not impaired by morphine. Methods Find. Exp. Clin. Pharmacol. 18:1996;159-165.
68. Parrillo J.E., Fauci A.S. Mechanisms of glucocorticoid action on immune processes. Annu. Rev. Pharmacol. Toxicol. 19:1979;179-201.
69. Pechnick R.N. Effects of opioids on the hypothalamo-pituitary-adrenal axis. Annu. Rev. Pharmacol. Toxicol. 32:1993;353-382.
70. Peterson, P.K., Molitor, T.W., Chao, C.C., Sharp, B., 1990. Opiates and cell-mediated immunity. In: Watson, R.R. (Ed.), Drugs of Abuse and Immune Function. CRC Press, Boca Raton, FL, pp. 1-18.
71. Peterson, P.K., Gekker, G., Schut, R., Hu, S., Balfour, H.H.J., Chao, C.C., 1993. Enhancement of HIV-1 replication by opiates and cocaine: The cytokine connection. In: Friedman, H., Klein, T.W., Specter, S. (Eds.), Adv. Exp. Med. Biol. Plenum Press, New York, pp. 181-188.
72. Peterson P.K., Gekker G., Hu S., Anderson W.R., Kravitz F., Portughese P.S., Balfour H.H.J., Chao C.C. Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J. Neuroimmunol. 50:1994;167-175.
73. Pfeiffer A., Feuerstein G., Faden A., Kopin I.J. Evidence for an involvement of mu-, but not delta- or kappa-opiate receptors in sympathetically and parasympathetically mediated cardiovascular responses to opiates upon anterior hypothalamic injection. Life Sci. 31:1982;1279-1282.
74. Radulović J., Miljević C., Djergović D., Vujić V., Antić J., von Horsten S., Janković B.D. Opioid receptor-mediated suppression of humoral immune response in vivo and in vitro: involvement of K opioid receptors. J. Neuroimmunol. 57:1995;55-62.
75. Radulović J., Janković B.D. Opposing activities of brain opioid receptors in the regulation of humoral and cell-mediated immune responses in the rat. Brain Res. 661:1994;189-195.
76. Risdahl J.M., Peterson P.K., Chao C.C., Pijoan C., Molitor T.W. Effects of morphine dependence on the pathogenesis of swine herpesvirus infection. J. Infect. Dis. 167:1993;1281-1287.
77. Schneider, G.M., Lysle, D.T., 1996. Effects of centrally administered opioid agonists on macrophage nitric oxide production and splenic lymphocyte proliferation. In: Friedman, H., Eisenstein, T.K., Madden, J., Sharp, B.M. (Eds.), Adv. Exp. Med. Biol., Vol. 402. Plenum Press, New York, pp. 81-88.
78. Shavit Y., Depaulis A., Martin F.C., Terman G.W., Pechnick R.N., Zane C.J., Gale R.P., Liebeskind J.C. Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc. Natl. Acad. Sci. U.S.A. 83:1986;7114-7117.
79. Starec M., Rouveix B., Sinet M., Chau F., Desforges B., Pocidalo J., Lechat P. Immune status and survival of opiate- and cocaine-treated mice infected with friend virus. J. Pharmacol. Exp. Ther. 259:1991;745-750.
80. Sternberg E.M., Hill J.M., Chrousos G.P., Kamilaris T., Listwak S.J., Gold P.W., Wilder R.L. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Natl. Acad. Sci. U.S.A. 86:1989;2374-2378.
81. Sternberg E.M., Young W.S. III, Bernardini R., Calogero A.E., Chrousos G.P., Gold P.W., Wilder R.L. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. U.S.A. 86:1989;4771-4775.
82. Tubaro E., Borelli G., Croce C., Cavallo G., Santiageli C. Effect of morphine on resistance to infection. J. Infect. Dis. 148:1983;656-666.
83. Veljić J., Marić D., Janković B.D. Effect of intracerebroventricularly injected methionine-enkephalin on humoral immune response in the rat. Period. Biol. 92:1990;73-74.
84. Veljić J., Ranin J., Marić D., Janković B.D. Modulation of cutaneous immune reactions by centrally applied methionine-enkephalin. Ann. NY Acad. Sci. 650:1992;51-55.
85. Vogel W.H., Miller J., DeTurck K.H., Routzahn B.K. Jr. Effect of psychoactive drugs on plasma catecholamines during stress in rats. Neuropharmacology. 23:1984;1105-1108.
86. Weber R.J., Pert A. The periaqueductal gray matter mediates opiate-induced immunosuppression. Science. 245:1989;188-190.
87. Yeager M.P., Yu C.T., Campbell A.S., Moschella M., Guyre P.M. Effect of morphine and β-endorphin on human Fc receptor-dependent and natural killer cell functions. Clin. Immunol. Immunopathol. 62:1992;336-343.
88. Yeager M.P., Colacchio T.A., Hildebrandt L., Howell A.L., Weiss J., Guyre P.M. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology. 83:1995;500-508.